Today, Bio-Works successfully passed the annual ISO-9001: 2015 inspection. The external auditor from Intertek has extended the certificate until 2022, with a number of recommendations for improvements but with no minor or major findings.
This is a significant accomplishment for all at Bio-Works and we are very proud of the team work and spirit of cooperation that have brought us this far.
Bio-Works quality management system became certified according to the international standard ISO 9001 in January 2019 and Bio-Works has been audited and approved by an external certification organization. The standard is harmonized with EU regulations and certification endorses the company’s ability to provide products that consistently meet both customer requirements and applicable legal requirements.
It is extremely gratifying to receive this external endorsement of our hard work in building and maintaining a system that reflects how we aspire every day to the highest level of quality in everything we do. Our customers in turn are benefiting, particularly in the current pandemic situation, from continued timely delivery of reliable products.
Bio-Works is a biotechnology company that develops, produces and sells innovative separation media products based on agarose to purify proteins, peptides and other biomolecules. The company's products are mainly used for purifying biological drugs and diagnostic products, from the research phase to large-scale production. The products are sold globally partly through its own organization and partly through distributors. The Bio-Works facility is located in Uppsala Business Park in Uppsala, Sweden. The company's share is listed on Nasdaq First North. FNCA Sweden AB, +46 (0) 8-528 00 399, info@fnca.se, is appointed Certified Adviser.